Tumor necrosis factor and motoneuronal degeneration: An open problem

NeuroImmunoModulation

Volumn 9, Issue 4, 2001, Pages 178-182

  Ghezzi, Pietro ^a   Mennini, Tiziana ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ALLERGIC ENCEPHALITIS; AMYOTROPHIC LATERAL SCLEROSIS; AUTOIMMUNITY; HUMAN; MOTONEURON; MOTOR NEURON DISEASE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; AUTOIMMUNE DISEASES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MICE; MICE, NEUROLOGIC MUTANTS; MICE, TRANSGENIC; MOTOR NEURON DISEASE; MOTOR NEURONS; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVE GROWTH FACTORS; NEURONAL CEROID-LIPOFUSCINOSES; NEUROPROTECTIVE AGENTS; NF-KAPPA B; OXIDATIVE STRESS; RATS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035719745     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000049024     Document Type: Review

References (51)

1. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis
2. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
3. Increased intracellular calcium triggered by immune mechanisms in amyotrophic lateral sclerosis
4. In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients
5. Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis
6. An hereditary motor neurone disease with progressive denervation of muscle in the mouse: The mutant 'wobbler'
7. Wobbler, a mutation affecting motoneuron survival and gonadal functions in the mouse, maps to proximal chromosome 11
8. Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease)
9. Biochemical and pharmacological evidence of a functional role of AMPA receptors in motor neuron dysfunction in mnd mice
10. Spinal cord GLT-1 glutamate transporter and blood glutamic acid alterations in motor neuron degeneration (Mnd) mice
11. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis (FALS)
12. Proinflammatory cytokines as pathogenetic mediators in the central nervous system: Brain-periphery connections
13. When cytokines get on your nerves: Cytokine networks and CNS pathologies
14. Cytokines and their receptors in the central nervous system: Physiology, pharmacology, and pathology
15. Tumor necrosis factor receptor and fas signaling mechanisms
16. Tumor necrosis factor is increased in the spinal cord of an animal model of motor neuron degeneration
17. Astrocyte proliferation induced by wobbler astrocyte conditioned medium is blocked by tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) neutralizing antibodies in vitro
18. Death-inducing functions of ligands of the tumor necrosis factor family: A Sanhedrin verdict
19. Neuroprotection by encephalomyelitis: Rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells
20. Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain
21. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures
22. N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor production
23. From Charcot to SOD1: Mechanisms of selective motor neuron death in ALS
24. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial function. Evidence for the involvement of mitochondrial radical generation
25. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons
26. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
27. Soluble TNF receptors partially protect injured motoneurons in the postnatal CNS
28. NF-kappaB transcription factors: Critical regulators of he-matopoiesis and neuronal survival
29. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways
30. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis
31. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis
32. Some misconceptions about understanding autoimmunity through experiments with knockouts
33. TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
34. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritis
35. Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis
36. Inhibition of p75 tumor necrosis factor receptor by antisense oligonucleotides increases hypoxic injury and b-amyloid toxicity in human neuronal cell line
37. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor
38. Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes
39. TNF receptor p55 plays a major role in centrally mediated increases of serum IL-6 and corticosterone after intracerebroventricular injection of TNF
40. Tumor necrosis factor-alpha induces substance P in sympathetic ganglia through sequential induction of interleukin-1 and leukemia inhibitory factor
41. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130
42. Haemopoietic receptors and helical cytokines
43. The emerging neuropoietic cytokine family: First CDF/LIF, CNTF and IL- 6; next ONC, MGF, GCSF?
44. Novel neurotrophin-1/B cell-stimulating factor-3: A cytokine of the IL- 6 family
45. Neuroprotective effect of various cytokines on developing spinal motoneurons following axotomy
46. Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease
47. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF
48. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy
49. Innate and adaptive immune responses can be beneficial for CNS repair
50. Autoimmune maintenance and neuroprotection of the central nervous system